ATE133944T1 - Substituierte aminopyrimidine als angiotensin ii antagonisten - Google Patents

Substituierte aminopyrimidine als angiotensin ii antagonisten

Info

Publication number
ATE133944T1
ATE133944T1 AT92922669T AT92922669T ATE133944T1 AT E133944 T1 ATE133944 T1 AT E133944T1 AT 92922669 T AT92922669 T AT 92922669T AT 92922669 T AT92922669 T AT 92922669T AT E133944 T1 ATE133944 T1 AT E133944T1
Authority
AT
Austria
Prior art keywords
compounds
useful
angiotensin
antagonists
aminopyrimidines
Prior art date
Application number
AT92922669T
Other languages
English (en)
Inventor
Dimitrios Sarantakis
James Jacob Bicksler
John Watson Ellingboe
Madelene Antane
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Application granted granted Critical
Publication of ATE133944T1 publication Critical patent/ATE133944T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT92922669T 1991-10-24 1992-10-22 Substituierte aminopyrimidine als angiotensin ii antagonisten ATE133944T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78202691A 1991-10-24 1991-10-24
US07/900,639 US5336677A (en) 1991-10-24 1992-06-18 Substituted aminopyrimidines as antihypertensives

Publications (1)

Publication Number Publication Date
ATE133944T1 true ATE133944T1 (de) 1996-02-15

Family

ID=27119939

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92922669T ATE133944T1 (de) 1991-10-24 1992-10-22 Substituierte aminopyrimidine als angiotensin ii antagonisten

Country Status (12)

Country Link
US (1) US5336677A (de)
EP (1) EP0611368B1 (de)
JP (1) JPH07500598A (de)
AT (1) ATE133944T1 (de)
AU (1) AU2889692A (de)
CA (1) CA2121815A1 (de)
DE (1) DE69208263T2 (de)
DK (1) DK0611368T3 (de)
ES (1) ES2085043T3 (de)
GR (1) GR3019543T3 (de)
PT (1) PT100987B (de)
WO (1) WO1993008169A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034114A (en) * 1990-12-14 2000-03-07 Smithkline Beecham Plc Medicament
US6028091A (en) * 1990-12-14 2000-02-22 Smithkline Beecham Plc Medicament
US5283242A (en) * 1991-10-24 1994-02-01 American Home Products Corporation Substituted benzimidazoles and quinazolines as antihypertensives
GB9217820D0 (en) * 1992-08-21 1992-10-07 Fujisawa Pharmaceutical Co New use
AU8996698A (en) * 1997-09-10 1999-03-29 Ono Pharmaceutical Co. Ltd. Peroxisome proliferator-activated receptor controllers
US6440965B1 (en) 1997-10-15 2002-08-27 Krenitsky Pharmaceuticals, Inc. Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
US6583148B1 (en) 1999-04-08 2003-06-24 Krenitsky Pharmaceuticals, Inc. Neurotrophic substituted pyrimidines
CA2416442C (en) 2000-07-24 2010-06-08 Krenitsky Pharmaceuticals, Inc. Substituted 5-alkynyl pyrimidines having neurotrophic activity
RU2007110731A (ru) * 2004-09-23 2008-10-27 Редди Юс Терапевтикс Новые соединения пиримидина, способ их получения и содержащие их композиции
US8097109B2 (en) * 2004-12-14 2012-01-17 The Proctor & Gamble Company Method for the concurrent converting of multiple web materials
EP1749828A1 (de) * 2005-08-04 2007-02-07 Farmaprojects S.L. Verfahren zur Herstellung eines Angiotensin-II-Antagonisten
JP5238172B2 (ja) * 2007-03-22 2013-07-17 公益財団法人相模中央化学研究所 パーフルオロアルキル基を有する含窒素六員環化合物およびその製造方法
EA020466B1 (ru) 2007-06-04 2014-11-28 Синерджи Фармасьютикалз Инк. Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CN101397277B (zh) * 2008-01-10 2012-04-18 联化科技股份有限公司 一种氨甲基联苯四氮唑及其盐的合成方法、及其中间体及中间体的合成方法
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2009155448A1 (en) * 2008-06-20 2009-12-23 Ligand Pharmaceuticals Inc. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) * 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2012065963A2 (en) 2010-11-15 2012-05-24 Katholieke Universiteit Leuven Novel antiviral compounds
EP2970384A1 (de) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonisten der guanylatcyclase und deren verwendungen
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CN113388007A (zh) 2013-06-05 2021-09-14 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
EP3046912A1 (de) 2013-09-16 2016-07-27 Bayer Pharma Aktiengesellschaft Disubstituierte trifluormethylpyrimidinone und ihre verwendung als ccr2 antagonisten
WO2016113205A1 (de) 2015-01-13 2016-07-21 Bayer Pharma Aktiengesellschaft Substituierte pentafluorethylpyrimidinone und ihre verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100897A (en) * 1989-08-28 1992-03-31 Merck & Co., Inc. Substituted pyrimidinones as angiotensin ii antagonists
DE3934153A1 (de) * 1989-10-12 1991-04-18 Johnson & Johnson Gmbh Tampon, insbesondere fuer die frauenhygiene, sowie verfahren und vorrichtung zur herstellung desselben
EP0435827A3 (en) * 1989-12-28 1991-11-13 Ciba-Geigy Ag Diaza compounds
IE912956A1 (en) * 1990-09-10 1992-03-11 Abbott Lab Angiotensin ii receptor antagonists

Also Published As

Publication number Publication date
DE69208263T2 (de) 1996-07-18
WO1993008169A1 (en) 1993-04-29
AU2889692A (en) 1993-05-21
ES2085043T3 (es) 1996-05-16
EP0611368B1 (de) 1996-02-07
CA2121815A1 (en) 1993-04-29
EP0611368A1 (de) 1994-08-24
US5336677A (en) 1994-08-09
PT100987B (pt) 1999-07-30
PT100987A (pt) 1994-01-31
GR3019543T3 (en) 1996-07-31
JPH07500598A (ja) 1995-01-19
DK0611368T3 (da) 1996-06-03
DE69208263D1 (de) 1996-03-21

Similar Documents

Publication Publication Date Title
ATE133944T1 (de) Substituierte aminopyrimidine als angiotensin ii antagonisten
ATE161537T1 (de) Kondensierte pyrimidinderivate und deren verwendung als angiotensin-ii-antagonisten
DE69034103D1 (de) Imidazoalkensäure
YU54896A (sh) (methilsulfonil)fenil-2-(5h)-furanoni kao cox-2 inhibitori
DE69616480T2 (de) Piperidinderivate als neurokininantagonisten
ES2062403T3 (es) 5-((tetrazolil)-alquenil)-imidazoles sustituidos.
ATE316964T1 (de) Substituierte 4-amino-2-aryl-cyclopenta (d)pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
ATE324890T1 (de) Zusammensetzung enthaltend einen angiotensin-ii- rezeptor-antagonist und einen diuretikum und deren verwendung zur behandlung von bluthochdruck
AP9801202A0 (en) Atropisomers of 3-heteroaryl-4(3H)-quinazolinones.
ATE429421T1 (de) Arylindenopyridin- und arylindenopyrimidinverbindungen und ihre verwendung als adenosin-a2a-rezeptor antagonisten
DE69816047D1 (en) (methylsulfonyl)phenyl-2-(5h)-furanone mit sauerstoff-bindung als cox-2-hemmer
NO961333L (no) Nye pyrazolderivater som angiotensin-II-antagonister
DE69324910D1 (de) Triazolopyrimidinderivate als angiotensin-ii rezeptor antagonisten
ATE383343T1 (de) Imidazolderivate verwendbar als histamin h3 rezeptorliganden

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee